Okayasu S et al. |
A survey on diarrhea and convenience of intake associated with a single-dose extended release formulation of azithromycin. |
2011 |
Pharmazie |
pmid:21553656
|
Xue-Min Z et al. |
Determination of azithromycin in human plasma by LC-MS-MS and its pharmacokinetics. |
2007 |
Pharmazie |
pmid:17484278
|
Togami K et al. |
Transport characteristics of clarithromycin, azithromycin and telithromycin, antibiotics applied for treatment of respiratory infections, in Calu-3 cell monolayers as model lung epithelial cells. |
2012 |
Pharmazie |
pmid:22764569
|
Hamdan II |
Comparative in vitro investigations of the interaction between some macrolides and Cu(II), Zn(II) and Fe(II). |
2003 |
Pharmazie |
pmid:12685822
|
Odendaal RW et al. |
A novel reversed-phase LC method for quantitative detection of azithromycin in bulk drug and tablet formulations in various aqueous media. |
2012 |
Pharmazie |
pmid:23346759
|
Najib MM et al. |
Cost-effectiveness of sparfloxacin compared with other oral antimicrobials in outpatient treatment of community-acquired pneumonia. |
2000 |
Pharmacotherapy |
pmid:10772376
|
Pollak PT and Slayter KL |
Reduced serum theophylline concentrations after discontinuation of azithromycin: evidence for an unusual interaction. |
1997 Jul-Aug |
Pharmacotherapy |
pmid:9250566
|
Bizjak ED et al. |
Intravenous azithromycin-induced ototoxicity. |
1999 |
Pharmacotherapy |
pmid:10030778
|
Toltzis P |
Comparison of amoxicillin with alternative agents for the treatment of acute otitis media in children. |
2005 |
Pharmacotherapy |
pmid:16305281
|
Shrader SP et al. |
Azithromycin and warfarin interaction. |
2004 |
Pharmacotherapy |
pmid:15303459
|
Gaylor AS and Reilly JC |
Therapy with macrolides in patients with cystic fibrosis. |
2002 |
Pharmacotherapy |
pmid:11837560
|
Beckey NP et al. |
Retrospective evaluation of a potential interaction between azithromycine and warfarin in patients stabilized on warfarin. |
2000 |
Pharmacotherapy |
pmid:10999497
|
Drew RH and Gallis HA |
Azithromycin--spectrum of activity, pharmacokinetics, and clinical applications. |
1992 |
Pharmacotherapy |
pmid:1319048
|
Page RL et al. |
Possible interaction between intravenous azithromycin and oral cyclosporine. |
2001 |
Pharmacotherapy |
pmid:11714218
|
Ernst EJ et al. |
Comparison of the serum and intracellular pharmacokinetics of azithromycin in healthy and diabetic volunteers. |
2000 |
Pharmacotherapy |
pmid:10853621
|
Prescott WA and Johnson CE |
Antiinflammatory therapies for cystic fibrosis: past, present, and future. |
2005 |
Pharmacotherapy |
pmid:15977917
|
Eschenauer G et al. |
Azithromycin-warfarin interaction: are we fishing with a red herring? |
2005 |
Pharmacotherapy |
pmid:15977924
|
Woodruff AE et al. |
Azithromycin-Induced, Biopsy-Proven Acute Interstitial Nephritis in an Adult Successfully Treated with Low-Dose Corticosteroids. |
2015 |
Pharmacotherapy |
pmid:26598102
|
Stevens RC et al. |
Pharmacokinetics of azithromycin after single- and multiple-doses in children. |
1997 Sep-Oct |
Pharmacotherapy |
pmid:9324176
|
Destache CJ et al. |
Microbiologic effect of bovine cerebrospinal fluid and azithromycin against Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae. |
1997 Sep-Oct |
Pharmacotherapy |
pmid:9324186
|
LaPlante KL et al. |
Prevalence of and risk factors for dysglycemia in patients receiving gatifloxacin and levofloxacin in an outpatient setting. |
2008 |
Pharmacotherapy |
pmid:18154478
|
Tilelli JA et al. |
Life-threatening bradyarrhythmia after massive azithromycin overdose. |
2006 |
Pharmacotherapy |
pmid:16506357
|
Petitta A et al. |
Economic evaluation of three methods of treating urogenital chlamydial infections in the emergency department. |
1999 |
Pharmacotherapy |
pmid:10331829
|
Foster DR and Milan NL |
Potential interaction between azithromycin and warfarin. |
1999 |
Pharmacotherapy |
pmid:10417043
|
McCall KL et al. |
Determination of the lack of a drug interaction between azithromycin and warfarin. |
2004 |
Pharmacotherapy |
pmid:14998219
|
Poachanukoon O et al. |
Macrolides attenuate phorbol ester-induced tumor necrosis factor-α and mucin production from human airway epithelial cells. |
2014 |
Pharmacology |
pmid:24556631
|
Parnham MJ et al. |
Azithromycin: mechanisms of action and their relevance for clinical applications. |
2014 |
Pharmacol. Ther. |
pmid:24631273
|
Di Paolo A et al. |
Pharmacokinetics of azithromycin in lung tissue, bronchial washing, and plasma in patients given multiple oral doses of 500 and 1000 mg daily. |
2002 |
Pharmacol. Res. |
pmid:12457629
|
Baschiera F et al. |
Improved tonsillar disposition of azithromycin following a 3-day oral treatment with 20 mg kg(-1) in paediatric patients. |
2002 |
Pharmacol. Res. |
pmid:12208127
|
Matijašić M et al. |
Fluorescently labeled macrolides as a tool for monitoring cellular and tissue distribution of azithromycin. |
2012 |
Pharmacol. Res. |
pmid:22749903
|
Banjanac M et al. |
Anti-inflammatory mechanism of action of azithromycin in LPS-stimulated J774A.1 cells. |
2012 |
Pharmacol. Res. |
pmid:22766077
|
Graziani F et al. |
Clinical evaluation of piroxicam-FDDF and azithromycin in the prevention of complications associated with impacted lower third molar extraction. |
2005 |
Pharmacol. Res. |
pmid:16140544
|
Bachmann K et al. |
Influence of a 3-day regimen of azithromycin on the disposition kinetics of cyclosporine A in stable renal transplant patients. |
2003 |
Pharmacol. Res. |
pmid:12742010
|
Marjanović N et al. |
Macrolide antibiotics broadly and distinctively inhibit cytokine and chemokine production by COPD sputum cells in vitro. |
2011 |
Pharmacol. Res. |
pmid:21315154
|
Szałek E et al. |
Sunitinib in combination with clarithromycin or azithromycin - is there a risk of interaction or not? |
2012 |
Pharmacol Rep |
pmid:23406766
|
He XJ et al. |
Influence of ABCB1 gene polymorphisms on the pharmacokinetics of azithromycin among healthy Chinese Han ethnic subjects. |
2009 Sep-Oct |
Pharmacol Rep |
pmid:19904007
|
Fohner AE et al. |
PharmGKB summary: Macrolide antibiotic pathway, pharmacokinetics/pharmacodynamics. |
2017 |
Pharmacogenet. Genomics |
pmid:28146011
|
Quach C et al. |
Effectiveness of amoxicillin, azithromycin, cefprozil and clarithromycin in the treatment of acute otitis media in children: a population-based study. |
2005 |
Pharmacoepidemiol Drug Saf |
pmid:15386697
|
Palcevski G et al. |
Antibiotic use profile at paediatric clinics in two transitional countries. |
2004 |
Pharmacoepidemiol Drug Saf |
pmid:15072118
|
Goldstein LH et al. |
Azithromycin is not associated with QT prolongation in hospitalized patients with community-acquired pneumonia. |
2015 |
Pharmacoepidemiol Drug Saf |
pmid:26238864
|
Bérard A et al. |
Use of macrolides during pregnancy and the risk of birth defects: a population-based study. |
2015 |
Pharmacoepidemiol Drug Saf |
pmid:26513406
|
Lea AP and Lamb HM |
Azithromycin. A pharmacoeconomic review of its use as a single-dose regimen in the treatment of uncomplicated urogenital Chlamydia trachomatis infections in women. |
1997 |
Pharmacoeconomics |
pmid:10174326
|
Zhong M et al. |
Azithromycin cationic non-lecithoid nano/microparticles improve bioavailability and targeting efficiency. |
2014 |
Pharm. Res. |
pmid:25208873
|
Wang Z and Meenach SA |
Synthesis and Characterization of Nanocomposite Microparticles (nCmP) for the Treatment of Cystic Fibrosis-Related Infections. |
2016 |
Pharm. Res. |
pmid:27091030
|
Curatolo W |
Interdisciplinary science and the design of a single-dose antibiotic therapy. |
2011 |
Pharm. Res. |
pmid:21311957
|
Curatolo W et al. |
Effects of food on a gastrically degraded drug: azithromycin fast-dissolving gelatin capsules and HPMC capsules. |
2011 |
Pharm. Res. |
pmid:21331473
|
Berquand A et al. |
Interaction of the macrolide antibiotic azithromycin with lipid bilayers: effect on membrane organization, fluidity, and permeability. |
2005 |
Pharm. Res. |
pmid:15835753
|
Chanteux H et al. |
Cell handling, membrane-binding properties, and membrane-penetration modeling approaches of pivampicillin and phthalimidomethylampicillin, two basic esters of ampicillin, in comparison with chloroquine and azithromycin. |
2003 |
Pharm. Res. |
pmid:12739771
|
Evans LA et al. |
Predicting injection site muscle damage. III: Evaluation of intramuscular formulations in the L6 cell model. |
1996 |
Pharm. Res. |
pmid:8899856
|
Curatolo W et al. |
Mechanistic study of the azithromycin dosage-form-dependent food effect. |
2010 |
Pharm. Res. |
pmid:20372991
|